Stavros G. Vizirgianakis - Oct 7, 2022 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
XTNT
Transactions as of
Oct 7, 2022
Transactions value $
$1,087,133
Form type
4
Date filed
10/11/2022, 04:48 PM
Previous filing
Aug 26, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock, $0.000001 par value Purchase $1.09M +2.26M +63.16% $0.48 5.85M Oct 7, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XTNT Warrant Purchase $0 +566K $0.00 566K Oct 7, 2022 Common Stock 566K $0.48 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in a second and final tranche of a private placement pursuant to a securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors.
F2 Includes 70,776 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
F3 This warrant was issued in a second and final tranche of a private placement pursuant to the securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors.
F4 This total does not include a warrant to purchase 878,770 shares of common stock issued on August 25, 2022. Such warrant was immediately exercisable as of the date of issuance and previously reported by the Reporting Person on a Form 4 filed with the Securities and Exchange Commission on August 26, 2022.